Erste Asset Management’s Abivax ABVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.6M Buy
110,000
+60,000
+120% +$6.79M 0.08% 215
2026
Q1
$5.08M Hold
50,000
– – 0.05% 271
2025
Q4
$7.02M Hold
50,000
– – 0.06% 229
2025
Q3
$4.17M Buy
+50,000
New +$3.07M 0.04% 272

Other funds holding ABVX

Erste Asset Management's ABVX Position: Q2 2026 in Review

Erste Asset Management increased its Abivax (ABVX) stake by 120% in Q2 2026, buying an estimated $6.79M and bringing the position to 110,000 shares worth $10.6M. The position accounts for 0.08% of the portfolio, ranked #215.

Erste Asset Management first reported a position in ABVX in Q3 2025 and has held it in 4 quarters since. 304 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • Erste Asset Management held 110,000 shares of Abivax worth $10.6M as of Q2 2026.
  • Erste Asset Management bought 60,000 Abivax shares in Q2 2026, an estimated $6.79M.
  • Abivax made up 0.08% of Erste Asset Management's portfolio in Q2 2026, its #215 holding.
  • Erste Asset Management first reported a position in Abivax in Q3 2025 and has held it in 4 quarters since.
  • 304 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on Erste Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.